(Philadelphia, PA) - In celebration of the extraordinary generosity and support of Leonard and Madlyn Abramson and their family to the University of Pennsylvania Cancer Center, the University of Pennsylvania has announced the renaming of its nationally recognized, National Cancer Institute-designated Comprehensive Cancer Center to the Abramson Cancer Center of the University of Pennsylvania.

"The Abramson's generosity has significantly advanced Penn's quest to unravel the biomedical mysteries of cancer in order to design better treatment options and ultimately find a cure," said Judith Rodin, PhD, president of the University of Pennsylvania. "With their extraordinary philanthropic vision and personal dedication to help all members of the cancer community, particularly patients and their loved ones, the Abramson commitment has enabled us to realize a new era in cancer treatment and research."

The Cancer Center is one of the largest in the country, with 345 members from 41 departments and eight schools of the University and over $120 million per year in external research grant funding. In 1997, the Abramsons announced a $100 million gift to establish The Leonard and Madlyn Abramson Family Cancer Research Institute at the University of Pennsylvania Cancer Center. "This was the largest such gift to a cancer center at the time and one of the largest donations ever received by the University," added Rodin.

According to Arthur H. Rubenstein, MB, BCh, executive vice president of the University of Pennsylvania for the Health System and dean of the School of Medicine, "The Abramson Institute has become a critically important research and clinical component of the Cancer Center and the University." Major scientific initiatives made possible by the extraordinary Abramson gift include programs in translational research, cancer cell biology, signal transduction, cancer genomics, and biomedical informatics. Currently, the Institute supports 27 Penn researchers and more than 250 personnel.

"We want to recognize the Abramson family and acknowledge the significant research and
clinical accomplishments made possible through their magnificent gift," said John H. Glick MD, director of the Abramson Cancer Center. "We decided that the fifth anniversary of the Abramson's gift was the appropriate time to celebrate and thank the Abramsons for making our Cancer Center what it is today.

"In addition to making possible numerous scientific accomplishments, the Abramsons have helped to transform the level of clinical cancer care and service excellence at the Cancer Center," added Glick.
Abramson-funded patient service coordinators, cancer nutritionists, and psychosocial counselors help patients and their families cope with the physical, emotional, and practical complexities of their care. Comprehensive cancer rehabilitation services and a service excellence training program also contribute to new levels of patient satisfaction.

"It is wonderful that the University is recognizing the Abramson family for its strong support of cancer research and treatment," said George Vande Woude, PhD, former scientific director of the National Cancer Institute and Director of the Van Andel Research Institute. "The Abramson family's investment in the Cancer Center has already had a profound effect on the cancer program of the University of Pennsylvania, helping to build a world-class cancer research program and develop new treatments for this disease, which affect one in three Americans."

Throughout its history, the Abramson Cancer Center of the University of Pennsylvania has been continuously recognized regionally and nationally for its contributions to patient care, research, professional education, and patient and community outreach. The Abramson Cancer Center is one of only 37 Comprehensive Cancer Centers approved and designated by the NCI. It was among the first cancer centers to receive this prestigious designation, and has continually maintained this status. The Abramson Cancer Center is also ranked fourth in research grant funding from the National Cancer Institute.

# # #

Editor's Note:

The following are available for interviews:

Judith Rodin, PhD, President, University of Pennsylvania

Arthur Rubenstein, MBBCh, Dean, University of Pennsylvania School of Medicine and Executive Vice President, University of Pennsylvania Health System

John, H. Glick, MD, Director, Abramson Cancer Center; Leonard and Madlyn Abramson Professor of
Clinical Oncology, University of Pennsylvania School of Medicine

Craig B. Thompson, MD, Scientific Director, Abramson Cancer Center; Chair, Department of Cancer Biology, University of Pennsylvania School of Medicine




Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.